DSIP Research Guide

This DSIP Research Guide is part of the Pyrox Labs Knowledge Hub — for laboratory and research use only. Not for human or veterinary use.

WHAT IS DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide originally isolated in 1974 from the cerebral venous blood of rabbits in induced slow-wave sleep, by the Schoenenberger–Monnier group in Switzerland. It was later studied by both Western European and Soviet/Russian research groups. This guide summarises the published literature on DSIP for laboratory researchers — including an important scientific caveat that researchers should be aware of before working with it.

RESEARCH BACKGROUND

Published literature — see this PubMed literature search — has explored areas including:

• Early human studies (small samples, 1980s) reporting effects on sleep duration, interruption frequency, and REM sleep following intravenous administration
• HPA-axis research, including a study finding DSIP reduced CRF-induced corticosterone release in preclinical models
• Broader physiological effects reported through the 1980s beyond sleep, including stress and withdrawal-related research

An important scientific caveat: the definitive modern review of this compound — Kovalzon & Strekalova, Journal of Neurochemistry, 2006, titled “Delta sleep-inducing peptide (DSIP): a still unresolved riddle” — explicitly states that DSIP’s existence as a discrete, well-defined endogenous regulatory peptide has not been robustly established. The original sleep-inducing effect reported in the 1970s work has not been reliably replicated in later, more rigorous research, and effects attributed to “DSIP” may reflect DSIP-like immunoreactive material bound to carrier proteins rather than a single free bioactive peptide with a defined receptor. There is essentially no active modern (post-2010) research programme investigating DSIP pharmacology — the published literature is dominated by primary work from the 1970s–1980s and periodic critical reviews. Pyrox Labs presents this history transparently rather than overstating DSIP’s mechanistic certainty.

PROPOSED MECHANISM OF ACTION

No specific DSIP receptor has ever been isolated or cloned, and its precursor protein was never conclusively identified. Proposed (speculative) mechanisms in the literature include interaction with the MAPK/ERK signalling cascade and structural homology to the glucocorticoid-induced leucine zipper (GILZ) protein. Given the unresolved questions raised by the modern literature review cited above, researchers should treat any described mechanism for DSIP as a historical hypothesis rather than settled pharmacology.

DSIP RESEARCH GUIDE — HANDLING & STORAGE

• Store lyophilised DSIP vials in a freezer (-20°C), protected from light, for long-term storage.
• Once reconstituted, store refrigerated (2–8°C) and use promptly, following the timeframe indicated by your research protocol.
• Use sterile technique and appropriate PPE when handling.
• See our Reconstitution Guide for general laboratory reconstitution reference information.

CERTIFICATES OF ANALYSIS

Independently tested for purity and identity. Search by product name and the batch/lot number printed on your vial label.

VIEW COA HUB →

FREQUENTLY ASKED QUESTIONS

Is DSIP approved for human use?
No. DSIP products sold by Pyrox Labs are not approved by any regulatory authority for human or veterinary use. They are sold strictly for laboratory and research purposes.

Can Pyrox Labs advise on dosing or administration?
No. We do not provide dosing, administration, or treatment guidance of any kind. Our team can only answer questions relating to order status, product specifications, and COA/testing documentation.

Is DSIP’s mechanism well established?
No — and researchers should know this going in. A widely cited 2006 review in the Journal of Neurochemistry describes DSIP’s status as a discrete endogenous peptide as an “unresolved riddle.” Treat published claims about its mechanism or effects with appropriate scientific caution.

How is DSIP supplied for laboratory research?
Pyrox Labs supplies DSIP as a lyophilised (freeze-dried) powder in a sealed research vial, accompanied by a Certificate of Analysis confirming purity and identity.